| _version_ |
1797287852632965120
|
| collection |
DOAJ
|
| first_indexed |
2024-03-07T18:40:36Z
|
| format |
Article
|
| id |
doaj.art-a4f612d8f49b4a1da78b7d1396a27169
|
| institution |
Directory Open Access Journal
|
| issn |
2572-9241
|
| language |
English
|
| last_indexed |
2024-03-07T18:40:36Z
|
| publishDate |
2018-10-01
|
| publisher |
Wiley
|
| record_format |
Article
|
| series |
HemaSphere
|
| spelling |
doaj.art-a4f612d8f49b4a1da78b7d1396a271692024-03-02T03:56:07ZengWileyHemaSphere2572-92412018-10-012353610.1097/01.HS9.0000547933.40071.ae201810003-00090P091 (0159) SERUM sCD30 AND TARC DO NOT CORRELATE WITH PET-BASED RESPONSE ASSESSMENT IN PATIENTS (PTS) WITH STAGE III OR IV CLASSICAL HODGKIN LYMPHOMA (cHL): PHASE 3 ECHELON-1 STUDY OF BRENTUXIMAB VEDOTIN PLUS CHEMOTHERAPY VS CHEMOTHERAPY ALONEhttp://journals.lww.com/10.1097/01.HS9.0000547933.40071.ae
|
| spellingShingle |
P091 (0159) SERUM sCD30 AND TARC DO NOT CORRELATE WITH PET-BASED RESPONSE ASSESSMENT IN PATIENTS (PTS) WITH STAGE III OR IV CLASSICAL HODGKIN LYMPHOMA (cHL): PHASE 3 ECHELON-1 STUDY OF BRENTUXIMAB VEDOTIN PLUS CHEMOTHERAPY VS CHEMOTHERAPY ALONE
HemaSphere
|
| title |
P091 (0159) SERUM sCD30 AND TARC DO NOT CORRELATE WITH PET-BASED RESPONSE ASSESSMENT IN PATIENTS (PTS) WITH STAGE III OR IV CLASSICAL HODGKIN LYMPHOMA (cHL): PHASE 3 ECHELON-1 STUDY OF BRENTUXIMAB VEDOTIN PLUS CHEMOTHERAPY VS CHEMOTHERAPY ALONE
|
| title_full |
P091 (0159) SERUM sCD30 AND TARC DO NOT CORRELATE WITH PET-BASED RESPONSE ASSESSMENT IN PATIENTS (PTS) WITH STAGE III OR IV CLASSICAL HODGKIN LYMPHOMA (cHL): PHASE 3 ECHELON-1 STUDY OF BRENTUXIMAB VEDOTIN PLUS CHEMOTHERAPY VS CHEMOTHERAPY ALONE
|
| title_fullStr |
P091 (0159) SERUM sCD30 AND TARC DO NOT CORRELATE WITH PET-BASED RESPONSE ASSESSMENT IN PATIENTS (PTS) WITH STAGE III OR IV CLASSICAL HODGKIN LYMPHOMA (cHL): PHASE 3 ECHELON-1 STUDY OF BRENTUXIMAB VEDOTIN PLUS CHEMOTHERAPY VS CHEMOTHERAPY ALONE
|
| title_full_unstemmed |
P091 (0159) SERUM sCD30 AND TARC DO NOT CORRELATE WITH PET-BASED RESPONSE ASSESSMENT IN PATIENTS (PTS) WITH STAGE III OR IV CLASSICAL HODGKIN LYMPHOMA (cHL): PHASE 3 ECHELON-1 STUDY OF BRENTUXIMAB VEDOTIN PLUS CHEMOTHERAPY VS CHEMOTHERAPY ALONE
|
| title_short |
P091 (0159) SERUM sCD30 AND TARC DO NOT CORRELATE WITH PET-BASED RESPONSE ASSESSMENT IN PATIENTS (PTS) WITH STAGE III OR IV CLASSICAL HODGKIN LYMPHOMA (cHL): PHASE 3 ECHELON-1 STUDY OF BRENTUXIMAB VEDOTIN PLUS CHEMOTHERAPY VS CHEMOTHERAPY ALONE
|
| title_sort |
p091 0159 serum scd30 and tarc do not correlate with pet based response assessment in patients pts with stage iii or iv classical hodgkin lymphoma chl phase 3 echelon 1 study of brentuximab vedotin plus chemotherapy vs chemotherapy alone
|
| url |
http://journals.lww.com/10.1097/01.HS9.0000547933.40071.ae
|